Mass. bioscience giant to buy Memphis-based Cognate BioServices for $875M

The massive deal is expected to close in the first quarter of 2021.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.